bisantrene has been researched along with mitoxantrone in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (76.47) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coltman, CA; Cowan, JD; Gumbart, C; Hutchins, LF; Martino, S; McClure, S; Neidhart, J; Osborne, CK; Stephens, RL; Vaughan, CB | 1 |
| Evdokimov, IuM; Palumbo, M; Salianov, VI | 1 |
| Novak, RF; Polverini, PJ | 1 |
| Alberts, DS; Dorr, RT; Einspahr, J; Milton, S; Remers, WA; Tunget, CL; Wunz, TP | 1 |
| Bron, D; Delforge, A; Dodion, P; Kenis, Y; Mattelaer, MA; Rozencweig, M; Stryckmans, P | 1 |
| Bishop, J; Coates, AS; Mann, GJ; Raghavan, D | 1 |
| Balaji, VN; Dixon, JS; Murdock, KC; Smith, DH; Venkataraghavan, R | 1 |
| Frank, P; Novak, RF | 1 |
| Constanzi, JJ; Cowan, JD; Neidhart, JA; Osborne, CK; Vaughn, CB; Von Hoff, DD | 1 |
| Alberts, DS; Bowden, GT; Garcia, D; Peng, YM; Roberts, R | 1 |
| Davies, KJ; Doroshow, JH | 1 |
| Clark, GM; Cowan, JD; Von Hoff, DD | 1 |
| Bradley, RD; Hanstock, CC; Lown, JW; Scraba, DG | 1 |
| Barlogie, B; Drewinko, B; Trujillo, JM; Yang, LY | 1 |
| Agbandje, M; Crofton-Sleigh, C; Jenkins, TC; Neidle, S; Venitt, S | 1 |
| Denny, WA; Feigon, J; Kearns, DR; Leupin, W | 1 |
| Allen, JD; Buitelaar, M; Schinkel, AH; Van Dort, SC; van Tellingen, O | 1 |
2 trial(s) available for bisantrene and mitoxantrone
| Article | Year |
|---|---|
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Female; Humans; Middle Aged; Mitoxantrone | 1991 |
A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
Topics: Adult; Aged; Alopecia; Anthracenes; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Female; Heart Failure; Humans; Leukopenia; Menopause; Middle Aged; Mitoxantrone; Nausea; Random Allocation; Receptors, Estrogen; Vomiting | 1985 |
15 other study(ies) available for bisantrene and mitoxantrone
| Article | Year |
|---|---|
[Study of the properties of condensed forms of the complexes of linear and supercoiled DNA with mitoxantrone and bisantrene].
Topics: Anthracenes; Chemical Phenomena; Chemistry; Circular Dichroism; DNA, Superhelical; Humans; Intercalating Agents; Mitoxantrone; Nucleic Acid Conformation | 1990 |
Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene.
Topics: Animals; Anthracenes; Antineoplastic Agents; Cornea; Culture Media; Mitoxantrone; Neovascularization, Pathologic; Rats | 1986 |
New antitumor agents containing the anthracene nucleus.
Topics: Animals; Anthracenes; Cell Line; Chemical Phenomena; Chemistry; DNA; Humans; Leukemia L1210; Leukemia P388; Mice; Mitoxantrone; Neoplasms; Protein Biosynthesis; RNA; Structure-Activity Relationship | 1987 |
Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives.
Topics: Anthracenes; Anthraquinones; Antineoplastic Agents; Bone Marrow; Cell Division; Cell Survival; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Mitoxantrone | 1986 |
Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene.
Topics: Aminoacridines; Amsacrine; Anthracenes; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Mitoxantrone; Phlebitis; Skin Neoplasms | 1986 |
Design of anticancer drugs using modeling techniques.
Topics: Anthracenes; Anthraquinones; Antineoplastic Agents; Base Sequence; Chemistry, Pharmaceutical; Computers; Crystallography; DNA; Intercalating Agents; Mathematics; Mitoxantrone; Models, Molecular; Protein Conformation; X-Ray Diffraction | 1985 |
Mitoxantrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro.
Topics: Adenosine Diphosphate; Adult; Anthracenes; Anthraquinones; Blood Platelets; Collagen; Dinoprostone; Epinephrine; Humans; Mitoxantrone; Platelet Aggregation; Prostaglandins E | 1985 |
Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.
Topics: Animals; Anthracenes; Anthraquinones; Antineoplastic Agents; Cell Nucleus; Cell Survival; DNA, Neoplasm; DNA, Single-Stranded; DNA, Superhelical; Leukemia L1210; Mice; Mitoxantrone | 1985 |
Comparative cardiac oxygen radical metabolism by anthracycline antibiotics, mitoxantrone, bisantrene, 4'-(9-acridinylamino)-methanesulfon-m-anisidide, and neocarzinostatin.
Topics: Aminoacridines; Amsacrine; Animals; Anthracenes; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Male; Mitochondria, Heart; Mitoxantrone; Myocardium; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum; Submitochondrial Particles; Superoxides; Zinostatin | 1983 |
Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system.
Topics: Anthracenes; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Separation; Cell Survival; Clone Cells; Colony-Forming Units Assay; Doxorubicin; Drug Evaluation; Humans; Lymph Nodes; Mitoxantrone; Neoplasms; Tumor Stem Cell Assay | 1983 |
Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
Topics: Anthracenes; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Chemical Phenomena; Chemistry; DNA; DNA, Superhelical; DNA, Viral; Microscopy, Electron; Mitoxantrone; Plasmids; Structure-Activity Relationship | 1984 |
Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro.
Topics: Anthracenes; Anthraquinones; Cell Line; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Humans; Mitoxantrone; Time Factors | 1983 |
Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity.
Topics: Animals; Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Agents; Escherichia coli; Male; Mitoxantrone; Mutagens; Mutation; Rats; Salmonella typhimurium | 1998 |
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
Topics: Antineoplastic Agents; Base Composition; Chemical Phenomena; Chemistry; DNA; Hydrogen Bonding; Intercalating Agents; Kinetics; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 1984 |
Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; Biological Transport; Cell Line; Dogs; Drug Resistance, Neoplasm; Etoposide; Male; Mice; Mice, Knockout; Neoplasm Proteins | 2003 |